Groowe Groowe / Newsroom / DCOY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

DCOY News

Decoy Therapeutics Inc. Common Stock

Decoy Therapeutics to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference Ready to Announce with Confidence?

newsfilecorp.com
DCOY

Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMP³ACT™ Platform

prnewswire.com
DCOY

Decoy Therapeutics Announces Breakthrough In Vitro Activity Against Ebola Zaire, Expanding D-MAV™ Platform into High Consequence Global Health Threats

prnewswire.com
DCOY

Form 8-K

sec.gov
DCOY

Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors

prnewswire.com
DCOY

4 Sizzling Biotech and Healthcare Companies Reporting Strategic Milestones

globenewswire.com
UPC NTHI DCOY VRDN

Form 8-K

sec.gov
DCOY

Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing

prnewswire.com
DCOY

Decoy Therapeutics' CEO to Participate in hVIVO Capital Markets Day in London

prnewswire.com
DCOY

Decoy Therapeutics Nominates Global Biopharma Executive Patricia Gauthier for Election to Board of Directors

prnewswire.com
DCOY